Another investigation found that a blockade of the α2A-adrenoceptor with BRL-44408 suppresses early pro-inflammatory mediators (TNF-α, IL-6, etc.)and, thus, improves liver dysfunction during sepsis [31]. This evidence concerns the gene IL6 and Decreased liver function.